Loading…

Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor κB signaling

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 2003-12, Vol.63 (24), p.8600-8605
Main Authors: RAKITINA, Tatiana V, VASILEVSKAYA, Irina A, O'DWYER, Peter J
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 8605
container_issue 24
container_start_page 8600
container_title Cancer research (Chicago, Ill.)
container_volume 63
creator RAKITINA, Tatiana V
VASILEVSKAYA, Irina A
O'DWYER, Peter J
description
format article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_15382604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15382604</sourcerecordid><originalsourceid>FETCH-LOGICAL-p183t-49bec6af760c0b960af9651c18b9e7b2486022ffbd73936746e663d3381165563</originalsourceid><addsrcrecordid>eNo1UMtKAzEUHUTBWv2HbFwGksljZpa1-IKCG12XO3m0kUwyJFPpfI6_4Uf4TUaqcOBy4HAe96xaUMFa3HAuzqsFIaTFgjf1ZXWV83uhghKxqD5XWrvJfRjkwmQSqMnFgKJF8QjejR4mFxAEjWiDwfvZw-BCxIVpM5hpH4_zzngNAYZZFWmBir5YKAjKJKSM98i7YDJKJh_8lJFNcSi6vevdf1g4KG8gIVvyY0LfX3cou10oDcLuurqw4LO5-bvL6u3h_nX9hDcvj8_r1QaPtGUT5l1vlATbSKJI30kCtpOCKtr2nWn6mreS1LW1vW5Yx2TDpZGSacZaSqUQki2r25PvCFmBt6kMcHk7JjdAmre_z6wl4ewHA49rgg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor κB signaling</title><source>EZB Electronic Journals Library</source><creator>RAKITINA, Tatiana V ; VASILEVSKAYA, Irina A ; O'DWYER, Peter J</creator><creatorcontrib>RAKITINA, Tatiana V ; VASILEVSKAYA, Irina A ; O'DWYER, Peter J</creatorcontrib><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Medical sciences ; Pharmacology. Drug treatments ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2003-12, Vol.63 (24), p.8600-8605</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15382604$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>RAKITINA, Tatiana V</creatorcontrib><creatorcontrib>VASILEVSKAYA, Irina A</creatorcontrib><creatorcontrib>O'DWYER, Peter J</creatorcontrib><title>Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor κB signaling</title><title>Cancer research (Chicago, Ill.)</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNo1UMtKAzEUHUTBWv2HbFwGksljZpa1-IKCG12XO3m0kUwyJFPpfI6_4Uf4TUaqcOBy4HAe96xaUMFa3HAuzqsFIaTFgjf1ZXWV83uhghKxqD5XWrvJfRjkwmQSqMnFgKJF8QjejR4mFxAEjWiDwfvZw-BCxIVpM5hpH4_zzngNAYZZFWmBir5YKAjKJKSM98i7YDJKJh_8lJFNcSi6vevdf1g4KG8gIVvyY0LfX3cou10oDcLuurqw4LO5-bvL6u3h_nX9hDcvj8_r1QaPtGUT5l1vlATbSKJI30kCtpOCKtr2nWn6mreS1LW1vW5Yx2TDpZGSacZaSqUQki2r25PvCFmBt6kMcHk7JjdAmre_z6wl4ewHA49rgg</recordid><startdate>20031215</startdate><enddate>20031215</enddate><creator>RAKITINA, Tatiana V</creator><creator>VASILEVSKAYA, Irina A</creator><creator>O'DWYER, Peter J</creator><general>American Association for Cancer Research</general><scope>IQODW</scope></search><sort><creationdate>20031215</creationdate><title>Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor κB signaling</title><author>RAKITINA, Tatiana V ; VASILEVSKAYA, Irina A ; O'DWYER, Peter J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p183t-49bec6af760c0b960af9651c18b9e7b2486022ffbd73936746e663d3381165563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RAKITINA, Tatiana V</creatorcontrib><creatorcontrib>VASILEVSKAYA, Irina A</creatorcontrib><creatorcontrib>O'DWYER, Peter J</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RAKITINA, Tatiana V</au><au>VASILEVSKAYA, Irina A</au><au>O'DWYER, Peter J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor κB signaling</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><date>2003-12-15</date><risdate>2003</risdate><volume>63</volume><issue>24</issue><spage>8600</spage><epage>8605</epage><pages>8600-8605</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2003-12, Vol.63 (24), p.8600-8605
issn 0008-5472
1538-7445
language eng
recordid cdi_pascalfrancis_primary_15382604
source EZB Electronic Journals Library
subjects Antineoplastic agents
Biological and medical sciences
Medical sciences
Pharmacology. Drug treatments
Tumors
title Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor κB signaling
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A43%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Additive%20interaction%20of%20oxaliplatin%20and%2017-allylamino-17-demethoxygeldanamycin%20in%20colon%20cancer%20cell%20lines%20results%20from%20inhibition%20of%20nuclear%20factor%20%CE%BAB%20signaling&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=RAKITINA,%20Tatiana%20V&rft.date=2003-12-15&rft.volume=63&rft.issue=24&rft.spage=8600&rft.epage=8605&rft.pages=8600-8605&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E15382604%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p183t-49bec6af760c0b960af9651c18b9e7b2486022ffbd73936746e663d3381165563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true